Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.

NCT06637189 is registered in ClinicalTrials.gov with Ginefiv as lead sponsor.

NCT NCT06637189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06637189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.
Lead sponsor
Ginefiv
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 15, 2024
Completion date
December 31, 2025
Enrollment
144 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

blastocyst, embryo, fertilization in vitro, oocyte, oocyte retrieval, pgt-a, stimulation in the ovary